BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 34530865)

  • 21. Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor α to gp130 expression: fusing experimental insights and dynamic modelling.
    Reeh H; Rudolph N; Billing U; Christen H; Streif S; Bullinger E; Schliemann-Bullinger M; Findeisen R; Schaper F; Huber HJ; Dittrich A
    Cell Commun Signal; 2019 May; 17(1):46. PubMed ID: 31101051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling.
    Tanuma N; Shima H; Nakamura K; Kikuchi K
    Blood; 2001 Nov; 98(10):3030-4. PubMed ID: 11698287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The roles of SOCS3 and STAT3 in bacterial infection and inflammatory diseases.
    Gao Y; Zhao H; Wang P; Wang J; Zou L
    Scand J Immunol; 2018 Dec; 88(6):e12727. PubMed ID: 30341772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
    J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
    Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
    J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting.
    Zanders L; Kny M; Hahn A; Schmidt S; Wundersitz S; Todiras M; Lahmann I; Bandyopadhyay A; Wollersheim T; Kaderali L; Luft FC; Birchmeier C; Weber-Carstens S; Fielitz J
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):713-727. PubMed ID: 34821076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activating mutations of the gp130/JAK/STAT pathway in human diseases.
    Lokau J; Garbers C
    Adv Protein Chem Struct Biol; 2019; 116():283-309. PubMed ID: 31036294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation.
    Boyle K; Zhang JG; Nicholson SE; Trounson E; Babon JJ; McManus EJ; Nicola NA; Robb L
    Cell Signal; 2009 Mar; 21(3):394-404. PubMed ID: 19056487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
    Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
    Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and function of a new STAT-induced STAT inhibitor.
    Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
    Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
    Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain.
    Zhang L; Badgwell DB; Bevers JJ; Schlessinger K; Murray PJ; Levy DE; Watowich SS
    Mol Cell Biochem; 2006 Aug; 288(1-2):179-89. PubMed ID: 16718380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 6 Promotes
    Hop HT; Huy TXN; Reyes AWB; Arayan LT; Vu SH; Min W; Lee HJ; Kang CK; Kim DH; Tark DS; Kim S
    Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31451617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6/IFN-γ-induced vascular smooth muscle cells.
    Xiang S; Dong NG; Liu JP; Wang Y; Shi JW; Wei ZJ; Hu XJ; Gong L
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):615-622. PubMed ID: 24142708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants governing the potency of STAT3 activation via the individual STAT3-recruiting motifs of gp130.
    Lehmann U; Sommer U; Smyczek T; Hörtner M; Frisch W; Volkmer-Engert R; Heinrich PC; Schaper F; Haan S
    Cell Signal; 2006 Jan; 18(1):40-9. PubMed ID: 15927449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid 1 receptor and interleukin-6 receptor together induce integration of protein kinase and transcription factor signaling to trigger neurite outgrowth.
    Zorina Y; Iyengar R; Bromberg KD
    J Biol Chem; 2010 Jan; 285(2):1358-70. PubMed ID: 19861414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A shift in the IL-6/STAT3 signalling pathway imbalance towards the SHP2 pathway in severe asthma results in reduced proliferation process.
    Salem IH; Plante S; Gounni AS; Rouabhia M; Chakir J
    Cell Signal; 2018 Mar; 43():47-54. PubMed ID: 29242170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.